|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 9/12 | (2006.01) |
| A61K | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 31/57 | (2006.01) | ||
| A61K 47/06 | (2006.01) | ||
| A61K 47/12 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 47/34 | (2006.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Patento numeris | 1073417 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 99916921.2 |
| Europos patento paraiškos padavimo data | 1999-04-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2001-02-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2002-12-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP9902/535 |
| Data | 1999-04-15 |
| (87) | Numeris | WO 9905/3901 |
| Data | 1999-10-28 |
| (30) | Numeris | Data | Šalis |
| 9808152 | 1998-04-18 | GB | |
| 9814709 | 1998-07-08 | GB |
| (72) |
CAVAILLON, P., Lab. Glaxo Wellcome, Zone Ind. no2, FR
LLORCA, N., Lab. Glaxo Wellcome, Zone Ind. no2, FR
LOUIS, O., Lab. Glaxo Wellcome, Zone Ind. No 2, FR
ROSIER, P., Lab. Glaxo Wellcome, Zone Ind. no. 2, FR
|
| (73) |
GLAXO GROUP LIMITED,
Glaxo Wellcome House, Berkeley Avenue,, Greenford, Middlesex UB6 0NN,
GB
|
| (54) | PHARMACEUTICAL AEROSOL FORMULATION |
| PHARMACEUTICAL AEROSOL FORMULATION |